View of Prognostic value of pretreatment systemic inflammation response index (SIRI) for survival in patients with advanced non-small cell lung cancer treated with first-generation EGFR-TKIs | Hue Journal of Medicine and Pharmacy

← Prognostic value of pretreatment systemic inflammation response index (SIRI) for survival in patients with advanced non-small cell lung cancer treated with first-generation EGFR-TKIs